← Back to All Filings
IDEXX Laboratories Director Joseph L. Hooley Acquires Deferred Stock Units
IDEXX LABORATORIES INC /DE
$IDXX4CIK: 0000874716
Subscribe to track IDXX
Premium users can add ticker alerts and receive realtime notification updates.
Filing Summary
=== SEC FORM 4 INSIDER TRANSACTION ===
Company: IDEXX LABORATORIES INC /DE (IDXX)
Insider: HOOLEY JOSEPH L
Title: Director
Transaction: Acquisition (Code A - Deferred Compensation Plan)
Date: 2026-10-30
Shares: 48
Price: $551.21
Total Value: $26,458.08
Post Holdings: 373 shares
Significance: Low (Routine Director Fee Deferral)
Comprehensive Analysis
Executive Summary
On November 3, 2026, IDEXX Laboratories, Inc. (NASDAQ: IDXX) filed a Form 4 disclosing that Director Joseph L. Hooley acquired 48 shares of Common Stock (in the form of deferred stock units) on October 30, 2026 at an effective price of $551.21 per share, totaling approximately $26,458.08.
Transaction Context
- Plan Participation: The units were acquired pursuant to the IDEXX Laboratories, Inc. Director Deferred Compensation Plan, deferring $26,250.00 of director cash compensation into deferred stock units based on the stock's closing price.
- Vesting & Delivery: The deferred stock units vested immediately upon grant and are payable in common stock following Mr. Hooley's resignation from the Board of Directors or on other predetermined dates under the plan.
- Post-Transaction Holdings: Following this award, Mr. Hooley directly holds 373 shares.
Market & Trading Significance
- Significance Rating: Low
- Analysis: This is a routine quarterly director compensation deferral rather than an open-market discretionary purchase or sale. While it aligns director incentives with equity performance, it does not convey an incremental speculative signal about company prospects.
Get Real-Time Alerts
Join our community to receive instant notifications when high-significance filings are published
Important Disclaimer
This content is drawn from public SEC filings and may contain errors. It is for informational purposes only and is not investment, legal, or tax advice.
Nothing here is a recommendation to buy, sell, or hold any security. Do your own due diligence.